We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Goldfinch

News List

Goldfinch Bio raises $100m to develop therapies for kidney diseases pharmaceutical-business-review
July 06, 2020
Goldfinch Bio has raised $100m in a Series B funding round for the discovery and development of precision drugs for the treatment of kidney diseases.
Gilead, Goldfinch Enter Kidney Collaboration contractpharma
May 10, 2019
Gilead Sciences and Goldfinch Bio have entered a collaboration to discover, develop and commercialize a pipeline of therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.
Gilead, Goldfinch to team up against kidney disease pharmatimes
May 09, 2019
Gilead and Goldfinch Bio have collaborated to discover, develop and commercialise a pipeline of innovative therapeutics for diabetic kidney disease (DKD) and certain orphan kidney diseases.
Optibrium and Goldfinch Bio sign agreement for StarDrop license cphi-online
May 10, 2017
Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery.